Topic Chronic Lymphocytic Leukemia (CLL)
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomics in Chronic Lymphocytic Leukemia: Current Research & Future Implications
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0218Published: Feb 2018Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: OncologySpecialties: OncologyTopics: Chronic Lymphocytic Leukemia (CLL) , Genomics -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomics in Chronic Lymphocytic Leukemia: Current Research & Future Implications ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0218Published: Feb 2018Expires: 1/1/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: OncologySpecialties: OncologyTopics: Chronic Lymphocytic Leukemia (CLL) , Genomics -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Novel Drug Development in CLL & HNLA
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0716Published: Jul 2016Expires: 1/1/2026Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Novel Drug Development in CLL & HNLA ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0716Published: Jul 2016Expires: 1/1/2026Sources: Oncology TimesDetails
